Daniel Wendorff joins Qiagen as Vice President, Investor Relations

Daniel Wendorff joined the German founded Biotech company, Qiagen as their Vice President, Investor Relations. Previously, Wendorff was Senior Director, Investor Relations at Merck having also been an Equity Research Analyst in both the healthcare and chemicals sectors for Oddo and Commerzbank.